Growth Metrics

Omnicell (OMCL) Asset Writedowns and Impairment (2016 - 2024)

Omnicell has reported Asset Writedowns and Impairment over the past 10 years, most recently at -$5.4 million for Q4 2024.

  • Quarterly Asset Writedowns and Impairment rose 30.9% to -$5.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$5.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $9.4 million for FY2022, N/A changed from the prior year.
  • Asset Writedowns and Impairment was -$5.4 million for Q4 2024 at Omnicell, down from $5.4 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $7.8 million in Q3 2023 and troughed at -$7.8 million in Q4 2023.
  • The 3-year median for Asset Writedowns and Impairment is $3.6 million (2022), against an average of $2.5 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 2505.0% in 2023 against a maximum downside of 296.26% in 2023.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $4.0 million in 2022, then plummeted by 296.26% to -$7.8 million in 2023, then soared by 30.9% to -$5.4 million in 2024.
  • Per Business Quant, the three most recent readings for OMCL's Asset Writedowns and Impairment are -$5.4 million (Q4 2024), $5.4 million (Q2 2024), and -$7.8 million (Q4 2023).